636 related articles for article (PubMed ID: 32962164)
1. Human Pluripotent Stem Cell-Derived Neural Cells as a Relevant Platform for Drug Screening in Alzheimer's Disease.
Garcia-Leon JA; Caceres-Palomo L; Sanchez-Mejias E; Mejias-Ortega M; Nuñez-Diaz C; Fernandez-Valenzuela JJ; Sanchez-Varo R; Davila JC; Vitorica J; Gutierrez A
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962164
[TBL] [Abstract][Full Text] [Related]
2. Modeling amyloid beta and tau pathology in human cerebral organoids.
Gonzalez C; Armijo E; Bravo-Alegria J; Becerra-Calixto A; Mays CE; Soto C
Mol Psychiatry; 2018 Dec; 23(12):2363-2374. PubMed ID: 30171212
[TBL] [Abstract][Full Text] [Related]
3. A three-dimensional human neural cell culture model of Alzheimer's disease.
Choi SH; Kim YH; Hebisch M; Sliwinski C; Lee S; D'Avanzo C; Chen H; Hooli B; Asselin C; Muffat J; Klee JB; Zhang C; Wainger BJ; Peitz M; Kovacs DM; Woolf CJ; Wagner SL; Tanzi RE; Kim DY
Nature; 2014 Nov; 515(7526):274-8. PubMed ID: 25307057
[TBL] [Abstract][Full Text] [Related]
4. Human iPSC-Derived Neural Models for Studying Alzheimer's Disease: from Neural Stem Cells to Cerebral Organoids.
Barak M; Fedorova V; Pospisilova V; Raska J; Vochyanova S; Sedmik J; Hribkova H; Klimova H; Vanova T; Bohaciakova D
Stem Cell Rev Rep; 2022 Feb; 18(2):792-820. PubMed ID: 35107767
[TBL] [Abstract][Full Text] [Related]
5. Alzheimer's disease and synapse Loss: What can we learn from induced pluripotent stem Cells?
Rodriguez-Jimenez FJ; Ureña-Peralta J; Jendelova P; Erceg S
J Adv Res; 2023 Dec; 54():105-118. PubMed ID: 36646419
[TBL] [Abstract][Full Text] [Related]
6. The Breakthroughs and Caveats of Using Human Pluripotent Stem Cells in Modeling Alzheimer's Disease.
Sahlgren Bendtsen KM; Hall VJ
Cells; 2023 Jan; 12(3):. PubMed ID: 36766763
[TBL] [Abstract][Full Text] [Related]
7. A 3D human triculture system modeling neurodegeneration and neuroinflammation in Alzheimer's disease.
Park J; Wetzel I; Marriott I; Dréau D; D'Avanzo C; Kim DY; Tanzi RE; Cho H
Nat Neurosci; 2018 Jul; 21(7):941-951. PubMed ID: 29950669
[TBL] [Abstract][Full Text] [Related]
8. Mouse induced pluripotent stem cells-derived Alzheimer's disease cerebral organoid culture and neural differentiation disorders.
Fan W; Sun Y; Shi Z; Wang H; Deng J
Neurosci Lett; 2019 Oct; 711():134433. PubMed ID: 31421155
[TBL] [Abstract][Full Text] [Related]
9. Self-Organizing 3D Human Neural Tissue Derived from Induced Pluripotent Stem Cells Recapitulate Alzheimer's Disease Phenotypes.
Raja WK; Mungenast AE; Lin YT; Ko T; Abdurrob F; Seo J; Tsai LH
PLoS One; 2016; 11(9):e0161969. PubMed ID: 27622770
[TBL] [Abstract][Full Text] [Related]
10. Modeling Sporadic Alzheimer's Disease in Human Brain Organoids under Serum Exposure.
Chen X; Sun G; Tian E; Zhang M; Davtyan H; Beach TG; Reiman EM; Blurton-Jones M; Holtzman DM; Shi Y
Adv Sci (Weinh); 2021 Sep; 8(18):e2101462. PubMed ID: 34337898
[TBL] [Abstract][Full Text] [Related]
11. N-butylidenephthalide attenuates Alzheimer's disease-like cytopathy in Down syndrome induced pluripotent stem cell-derived neurons.
Chang CY; Chen SM; Lu HE; Lai SM; Lai PS; Shen PW; Chen PY; Shen CI; Harn HJ; Lin SZ; Hwang SM; Su HL
Sci Rep; 2015 Mar; 5():8744. PubMed ID: 25735452
[TBL] [Abstract][Full Text] [Related]
12. A 3D human neural cell culture system for modeling Alzheimer's disease.
Kim YH; Choi SH; D'Avanzo C; Hebisch M; Sliwinski C; Bylykbashi E; Washicosky KJ; Klee JB; Brüstle O; Tanzi RE; Kim DY
Nat Protoc; 2015 Jul; 10(7):985-1006. PubMed ID: 26068894
[TBL] [Abstract][Full Text] [Related]
13. Simple modeling of familial Alzheimer's disease using human pluripotent stem cell-derived cerebral organoid technology.
Choe MS; Yeo HC; Kim JS; Lee J; Lee HJ; Kim HR; Baek KM; Jung NY; Choi M; Lee MY
Stem Cell Res Ther; 2024 Apr; 15(1):118. PubMed ID: 38659053
[TBL] [Abstract][Full Text] [Related]
14. The search for better animal models of Alzheimer's disease.
King A
Nature; 2018 Jul; 559(7715):S13-S15. PubMed ID: 30046083
[No Abstract] [Full Text] [Related]
15. Human neural cell type-specific extracellular vesicle proteome defines disease-related molecules associated with activated astrocytes in Alzheimer's disease brain.
You Y; Muraoka S; Jedrychowski MP; Hu J; McQuade AK; Young-Pearse T; Aslebagh R; Shaffer SA; Gygi SP; Blurton-Jones M; Poon WW; Ikezu T
J Extracell Vesicles; 2022 Jan; 11(1):e12183. PubMed ID: 35029059
[TBL] [Abstract][Full Text] [Related]
16. 3D culture models of Alzheimer's disease: a road map to a "cure-in-a-dish".
Choi SH; Kim YH; Quinti L; Tanzi RE; Kim DY
Mol Neurodegener; 2016 Dec; 11(1):75. PubMed ID: 27938410
[TBL] [Abstract][Full Text] [Related]
17. Modeling Alzheimer's Disease Using Human Brain Organoids.
Karmirian K; Holubiec M; Goto-Silva L; Fernandez Bessone I; Vitória G; Mello B; Alloatti M; Vanderborght B; Falzone TL; Rehen S
Methods Mol Biol; 2023; 2561():135-158. PubMed ID: 36399268
[TBL] [Abstract][Full Text] [Related]
18. Modelling Sporadic Alzheimer's Disease Using Induced Pluripotent Stem Cells.
Rowland HA; Hooper NM; Kellett KAB
Neurochem Res; 2018 Dec; 43(12):2179-2198. PubMed ID: 30387070
[TBL] [Abstract][Full Text] [Related]
19. Neural patterning of human induced pluripotent stem cells in 3-D cultures for studying biomolecule-directed differential cellular responses.
Yan Y; Bejoy J; Xia J; Guan J; Zhou Y; Li Y
Acta Biomater; 2016 Sep; 42():114-126. PubMed ID: 27345135
[TBL] [Abstract][Full Text] [Related]
20. Early pathogenic event of Alzheimer's disease documented in iPSCs from patients with PSEN1 mutations.
Yang J; Zhao H; Ma Y; Shi G; Song J; Tang Y; Li S; Li T; Liu N; Tang F; Gu J; Zhang L; Zhang Z; Zhang X; Jin Y; Le W
Oncotarget; 2017 Jan; 8(5):7900-7913. PubMed ID: 27926491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
